Gene · 1737
Papers2,650
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,650
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FDX1 as a predictive biomarker and therapeutic target for lymph node metastasis in gastric cancer. | Clin Exp Med | 2026 | 42107026 | PubTator, text mining | PubMed |
| GSH-Responsive Nanoparticles Enhance Hepatocellular Carcinoma Immunotherapy Through Synergistic Effects of Cuproptosis and PI3K Inhibitor Combination. | Adv Sci (Weinh) | 2026 | 42085613 | PubTator, text mining | PubMed |
| Lactylated NAT10 contributes to elesclomol-triggered cuproptosis via the NAT10/ac4C-DLAT-mRNA/DLAT positive feedback loop in CRC. | Proc Natl Acad Sci U S A | 2026 | 42085165 | PubTator, text mining | PubMed |
| GCSH promotes MASH progression by regulating cuproptosis through the glycine-GSH metabolic pathway. | Free Radic Biol Med | 2026 | 42082057 | PubTator, text mining | PubMed |
| Resveratrol inhibits aerobic glycolysis and promotes cuproptosis in acute myeloid leukemia via the PI3K/AKT signaling pathway. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 42056286 | PubTator, text mining | PubMed |
| USP15 stabilizes c-Myc to drive sunitinib resistance by suppressing cuproptosis in clear cell renal cell carcinoma. | Cell Rep | 2026 | 42054210 | PubTator, text mining | PubMed |
| [Ursolic acid in Huajie Xiaoliu Formula inhibits colorectal cancer cell growth by inducing cuproptosis]. | Nan Fang Yi Ke Da Xue Xue Bao | 2026 | 42045033 | PubTator, text mining | PubMed |
| GE11/RGD Dual-Ligand Copper Nanoassemblies Synchronize Cuproptosis and Photothermal Therapy for Targeted Cervical Cancer Ablation. | Mol Pharm | 2026 | 42044237 | PubTator, text mining | PubMed |
| NEU1 sustains mitochondria-lysosome contacts to trigger lysosomal Cu²+/cathepsin escape and mitochondrial lysis in glioblastoma (NeuLysis). | Neuro Oncol | 2026 | 42015369 | PubTator, text mining | PubMed |
| Advanced Glycation End Products Induce Cuproptosis and Then Promote the Activation and Migration of Cardiac Fibroblasts. | Int J Toxicol | 2026 | 42010979 | PubTator, text mining | PubMed |
| DLAT sustains redox homeostasis and prevent colorectal cancer from ferroptosis by regulating SLC25A39-mediated mitochondrial glutathione transport. | Free Radic Biol Med | 2026 | 42009144 | PubTator, text mining | PubMed |
| FSTL3-Driven Cuproptosis Resistance and EPCs Promote OSCC Metastasis. | J Dent Res | 2026 | 41996175 | PubTator, text mining | PubMed |
| DNA Logic Circuit-Equipped Redox Imbalance Amplifier for Precise Mitochondrial Disruption and Efficient Cancer Therapy. | Anal Chem | 2026 | 41952381 | PubTator, text mining | PubMed |
| Pareto-optimized stacked ensemble machine learning framework for predicting bearing capacity of driven piles from static load test data. | Sci Rep | 2026 | 41927741 | PubTator, text mining | PubMed |
| GSH-responsive triple-action photosensitizer nanoplatforms orchestrate cuproptosis-ferroptosis synergy to potentiate antitumor PDT efficacy. | J Nanobiotechnology | 2026 | 41923244 | PubTator, text mining | PubMed |
| Programmed cell death: a promising management for Alzheimer's disease. | Apoptosis | 2026 | 41904723 | PubTator, text mining | PubMed |
| Dermal Exposure to Heavy Metals in Urban Green Space Soils: A Review of Bioavailability, Toxic Mechanisms, and Precision Risk Assessment. | Toxics | 2026 | 41893504 | PubTator, text mining | PubMed |
| Multifaceted Role of Copper Homeostasis in Gut Health: From Molecular Mechanisms to Therapeutic Interventions. | Cells | 2026 | 41892335 | PubTator, text mining | PubMed |
| Temporal Integration of Serum Proteomics, Metabolomics and MRI Tumor Volumetrics via Deep Learning Identifies Systemic Mediators of Glioblastoma Response to Chemoradiotherapy. | Res Sq | 2026 | 41890862 | PubTator, text mining | PubMed |
| UFMylation of Pyruvate Dehydrogenase Regulates Mitochondrial Metabolism. | bioRxiv | 2026 | 41890053 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1737/papers?page=4